PF669 RUXOLITINIB TREATMENT AND RISK OF B-CELL LYMPHOMAS IN MYELOPROLIFERATIVE NEOPLASMS

Authors: C. Cavalloni, E. Rumi, S. Zibellini, E. Boveri, R. Riboni, I. Casetti, M. Ciboddo, C. Trotti, C. Favaron, D. Pietra, C. Candido, V. Ferretti, M. Cazzola, L. Arcaini

Published: 2019-06-17

DOI: 10.1097/01.hs9.0000560960.68270.0b

Source: Full article

---

Abstract

No abstract found.